Ligand Pharmaceuticals Inc. (LGND) to Acquire Metabasis Therapeutics, Inc. (MBRX) for Cash and Contingent Value Rights
10/27/2009 6:40:48 AM
More...
|
Metabasis Therapeutics, Inc. (MBRX) Receives Notice of Noncompliance with Nasdaq Listing Requirements
9/21/2009 10:46:18 AM
More...
|
Metabasis Therapeutics, Inc. (MBRX) Receives Notice of Delisting from Nasdaq Capital Market
9/10/2009 10:22:11 AM
More...
|
Metabasis Therapeutics, Inc. (MBRX) Hires Financial Advisor to Evaluate Strategic Alternatives
9/3/2009 9:58:18 AM
More...
|
Metabasis Therapeutics, Inc. (MBRX) Announces the Resignation of Mark Erion, Ph.D., President, CEO & CSO
9/1/2009 7:04:47 AM
More...
|
Metabasis Therapeutics, Inc. (MBRX)'s Massive Inventory Of Premium Lab & Analytical Equipment Now Available, EquipNet, Inc. Announces
8/13/2009 10:43:15 AM
More...
|
Metabasis Therapeutics, Inc. (MBRX) Announces Second Quarter 2009 Financial Results
8/7/2009 8:37:30 AM
More...
|
Metabasis Therapeutics, Inc. (MBRX) Announces Conference Call and Live Webcast to Discuss Second Quarter 2009 Financial Results
7/30/2009 9:30:33 AM
More...
|
Metabasis Therapeutics, Inc. (MBRX) Announces Merck & Co., Inc. (MRK) Has Selected a Lead AMPK Activator for Late Preclinical Development; Triggers $6 Million Payment to Metabasis
6/11/2009 7:58:53 AM
More...
|
Metabasis Therapeutics, Inc. (MBRX) Announces Corporate Restructuring; Reduces Workforce by Approximately 85%
5/27/2009 7:29:50 AM
More...
|
|